# Mesalamine

NDC: 63304-175
Generic name: Mesalamine
Labeler / Manufacturer: Sun Pharmaceutical Industries, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20190201

FDA application: ANDA211858

## Active ingredients

- MESALAMINE: 1.2 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63304-175"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63304-175
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd8b02de-7dfa-444d-a1f8-1436b578e0cb